🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)The sulfur burps are KILLING me someone help — 6 month update

The sulfur burps are KILLING me someone help — 6 month update

NeuroNate Mon, Aug 25, 2025 at 3:09 AM 14 replies 1,315 viewsPage 1 of 3
This thread is more than 9 months old. Information may be outdated. Consider searching for more recent discussions.
NeuroNate
Senior Member
2,890
16,789
Dec 2023
Chicago, IL
Aug 25, 2025 at 3:09 AM#1

The nausea I get is not really nausea, it is an aversion. Food I want in the abstract becomes repellent in front of me, which no side-effect list describes.

The bit I cannot resolve on my own is whether holding at a lower dose for longer actually reduces total side-effect burden or just spreads it out.

If the honest answer is that nobody knows, that is a useful answer and I would rather have it.

10 13jason_paloalto, Dr.LeslieOBGYN, MikeNYC_runner and 7 others
Reply Quote Save Share Report
COA_Karl
Senior Member
2,123
8,901
Jan 2024
Pennsylvania
Aug 25, 2025 at 3:48 AM#2

This one has a reasonably settled answer, so here it is. The line between titrate-through and stop is not severity, it is trajectory and what else is present. Nausea that peaks and improves within a week is the expected pattern. Nausea that is escalating, or that comes with severe upper-abdominal pain radiating to the back, or that prevents fluids for more than a day, is a different conversation and belongs with a clinician the same day.

11 14jim_asheville, matt_MKE, Dr.ReproEndo and 8 others
Reply Quote Save Share Report
carlos_SATX
Member
245
1,123
Oct 2024
San Antonio, TX
Aug 25, 2025 at 4:27 AM#3
COA_Karl said:
The line between titrate-through and stop is not severity, it is trajectory and what else is present.

Agreed on adaptation, with a caveat: adaptation applies to gastric emptying and not to everything. If your problem is the aversion rather than the fullness, waiting does less, because the aversion is central and it is the mechanism working as intended.

Last edited: Aug 25, 2025 at 6:27 AM
12 15Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 9 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
MikeKY_noInsulin
Member
267
1,234
Oct 2024
Louisville, KY
Aug 25, 2025 at 5:06 AM#4
NeuroNate said:
The nausea I get is not really nausea, it is an aversion.

Can confirm the pattern NeuroNate describes. The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the fat fraction of meals in the two days after dosing, and do not lie down straight after eating. Most of what people call unmanageable nausea is a meal-size and meal-composition problem interacting with a stomach that is emptying slowly.

13 16amy_econ_NJ, bbq_ray_KC, oliver_london and 10 others
Reply Quote Save Share Report
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Aug 25, 2025 at 8:42 AM#5

From the other side of the consultation, briefly. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

14 17mel_PDX, Dr.AddMedPHL, newstart_MO and 11 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register